Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 14, 676-680 (1 June 2008) | doi:10.1038/nm1769;
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
&
Abstract
An ideal vaccination strategy against tumors relies on specific antigens that are required for tumor maintenance. For lymphoma, vaccination with subject-specific immunoglobulin idiotypes has had the most promising results.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).